Prostate Cancer Symptoms Often Overlooked by Men

Inflammatory bowel disease, commonly known as IBD, refers to chronic conditions that cause inflammation in the digestive tract. The two main types are Crohn's disease and ulcerative colitis. These conditions can cause significant discomfort and health complications if not properly diagnosed and managed. Laboratory testing plays a crucial role in identifying IBD, monitoring disease activity, and distinguishing it from other gastrointestinal disorders.

Several blood tests are commonly used to help diagnose and monitor IBD. A complete blood count can reveal anemia, which often occurs in IBD patients due to chronic blood loss or poor nutrient absorption. Elevated white blood cell counts may indicate active inflammation. C-reactive protein and erythrocyte sedimentation rate are markers that measure inflammation levels in the body and help doctors assess disease activity. These tests are particularly useful for tracking how well treatment is working over time.

Stool tests provide valuable information about digestive tract inflammation and help rule out infections that can mimic IBD symptoms. Fecal calprotectin is a particularly important test that measures a protein released by white blood cells in the intestines. Elevated levels suggest inflammation in the digestive tract and can help distinguish IBD from irritable bowel syndrome, which does not involve inflammation. Stool cultures and tests for parasites help ensure that symptoms are not caused by infectious organisms.

Antibody tests can sometimes help differentiate between Crohn's disease and ulcerative colitis, though they are not definitive on their own. These include tests for anti-Saccharomyces cerevisiae antibodies, which are more common in Crohn's disease, and perinuclear anti-neutrophil cytoplasmic antibodies, which are more frequently found in ulcerative colitis. While these tests are not used alone to diagnose IBD, they provide additional information when combined with other clinical findings and imaging studies. Regular laboratory monitoring helps healthcare providers adjust treatment plans and catch potential complications early, improving long-term outcomes for people living with inflammatory bowel disease.